John Kelly
Founder chez ATOMO DIAGNOSTICS LIMITED
Fortune : 1 M $ au 31/03/2024
Profil
John Kelly is the founder of Atomo Diagnostics Ltd., where he currently holds the titles of Chief Executive Officer, Director, and MD.
Atomo Diagnostics Ltd.
was founded in 2010.
Mr. Kelly's former job was as the Chief Operating Officer at Unilife Corp.
Mr. Kelly's education history includes an undergraduate degree from The University of Liverpool, an MBA from The University of Sydney, and a graduate degree from Queen's University Belfast A.F.C.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ATOMO DIAGNOSTICS LTD.
11,34% | 03/08/2023 | 72 490 248 ( 11,34% ) | 1 M $ | 31/03/2024 |
Postes actifs de John Kelly
| Sociétés | Poste | Début |
|---|---|---|
| ATOMO DIAGNOSTICS LIMITED | Founder | 01/01/2010 |
Anciens postes connus de John Kelly
| Sociétés | Poste | Fin |
|---|---|---|
| UNILIFE CORP | Chief Operating Officer | - |
Formation de John Kelly
| The University of Liverpool | Undergraduate Degree |
| The University of Sydney | Masters Business Admin |
| Queen's University Belfast A.F.C. | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATOMO DIAGNOSTICS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Unilife Corp.
 Unilife Corp. Medical SpecialtiesHealth Technology Unilife Corp. designs, develops, manufactures and supplies injectable drug delivery systems. The company builds long-term collaborations with pharmaceutical and biotechnology companies seeking to utilize its devices to enable or enhance the clinical development, regulatory approval and lifecycle management of injectable therapies. The company was founded by Alan D. Shortall in 2001 and is headquartered in York, PA. | Health Technology |
